Flagship Ventures
T2 Biosystems Raises $10.8 Million in Series B Financing
T2 Biosystems, a company developing the first portable medical diagnostic products which combine nanotechnology and miniaturized magnetic resonance (MR) technology announced that it has raised $10.8 million in a Series B financing.
The company’s initial investors, Flagship Ventures, Polaris Venture Partners and Flybridge Capital Partners were joined by new investors Partners Healthcare and In-Q-Tel in the [...]
Financing for Concert Pharmaceuticals
CoNCERT Pharmaceuticals, Inc. Raises $37 Million in Series C Financing
CoNCERT Pharmaceuticals, Inc., announced the closing of a $37 million Series C financing today. The Company intends to use the proceeds to further advance its deuterium chemistry platform and product pipeline. The financing was led by a leading public equity institutional investor and included participation [...]
Recent Comments